# REducing Diabetic MacrovascUlar Complications DuE to Peripheral Arterial Disease- REDUCE-PAD

> **NCT05912218** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **National Heart Centre Singapore** · enrollment: 70 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2
- Peripheral Arterial Disease

## Interventions

- **BIOLOGICAL:** MEI6570

## Key facts

- **NCT ID:** NCT05912218
- **Lead sponsor:** National Heart Centre Singapore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-11-02
- **Primary completion:** 2025-09-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2024-11-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05912218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05912218, "REducing Diabetic MacrovascUlar Complications DuE to Peripheral Arterial Disease- REDUCE-PAD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05912218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*